Decreased clearance of diflunisal in renal insufficiency--an alternative explanation.
作者信息
Faed E M
出版信息
Br J Clin Pharmacol. 1980 Aug;10(2):185-6. doi: 10.1111/j.1365-2125.1980.tb01744.x.
Abstract
摘要
相似文献
1
Decreased clearance of diflunisal in renal insufficiency--an alternative explanation.肾功能不全时双氯芬酸清除率降低——另一种解释。
Br J Clin Pharmacol. 1980 Aug;10(2):185-6. doi: 10.1111/j.1365-2125.1980.tb01744.x.
2
Decreased body clearance of diflunisal in renal insufficiency--an alternative explanation.肾功能不全时双氟尼酸的体内清除率降低——另一种解释。
Br J Clin Pharmacol. 1979 Dec;8(6):601. doi: 10.1111/j.1365-2125.1979.tb01055.x.
3
Failure of alkaline diuresis to enhance diflunisal elimination.碱性利尿未能增强二氟尼柳的消除。
Br J Clin Pharmacol. 1980 Aug;10(2):163-5. doi: 10.1111/j.1365-2125.1980.tb01734.x.
4
Biliary excretion of diflunisal conjugates in patients with T-tube drainage.
Eur J Clin Pharmacol. 1988;34(4):423-6. doi: 10.1007/BF00542448.
5
Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies.剂量对人双氯芬酸葡萄糖醛酸化和硫酸化动力学的影响：单剂量研究
Br J Clin Pharmacol. 1988 Jul;26(1):31-9. doi: 10.1111/j.1365-2125.1988.tb03360.x.
6
Both phenolic and acyl glucuronidation pathways of diflunisal are impaired in liver cirrhosis.
Eur J Clin Pharmacol. 1992;42(5):471-4. doi: 10.1007/BF00314852.
7
Diflunisal disposition and hypouricemic response in osteoarthritis.
Clin Pharmacol Ther. 1983 Jun;33(6):813-21. doi: 10.1038/clpt.1983.111.
8
Glucuronidation and disposition of drug glucuronides in patients with renal failure. A review.肾衰竭患者中药物的葡萄糖醛酸化及葡萄糖醛酸苷的处置。综述。
Drug Metab Dispos. 1982 Jan-Feb;10(1):87-9.
9
Diflunisal and its conjugates in patients with renal failure.双氟尼酸及其结合物在肾衰竭患者中的情况。
Br J Clin Pharmacol. 1991 May;31(5):546-50. doi: 10.1111/j.1365-2125.1991.tb05578.x.
10
Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency.双氯芬酸在肾功能不全患者体内的生物转化及其葡糖醛酸苷的肾排泄
Br J Clin Pharmacol. 1979 Mar;7(3):273-82. doi: 10.1111/j.1365-2125.1979.tb00932.x.
引用本文的文献
1
The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis.肾功能对类风湿性关节炎患者酮洛芬对映体选择性药代动力学和药效学的影响。
Br J Clin Pharmacol. 1993 Sep;36(3):185-93. doi: 10.1111/j.1365-2125.1993.tb04215.x.
2
A high-pressure liquid chromatographic methods for the assay of ketoprofen in plasma and urine, and its application to determining the urinary excretion of free and conjugated ketoprofen following oral administrations of Orudis to man.一种用于测定血浆和尿液中酮洛芬的高压液相色谱法，及其在口服奥鲁地斯后人尿中游离和结合型酮洛芬排泄量测定中的应用。
Br J Clin Pharmacol. 1981 Apr;11(4):395-8. doi: 10.1111/j.1365-2125.1981.tb01142.x.
3
Dosage adjustment in renal insufficiency.肾功能不全时的剂量调整。
Br J Clin Pharmacol. 1982 Feb;13(2):145-53. doi: 10.1111/j.1365-2125.1982.tb01349.x.
4
Drug metabolites in renal failure: pharmacokinetic and clinical implications.肾衰竭中的药物代谢产物：药代动力学及临床意义
Clin Pharmacokinet. 1981 Sep-Oct;6(5):329-45. doi: 10.2165/00003088-198106050-00001.
5
Metabolism of amitriptyline in patients with chronic renal failure.慢性肾衰竭患者中阿米替林的代谢
Eur J Clin Pharmacol. 1984;26(2):227-32. doi: 10.1007/BF00630290.
6
Impaired elimination of lorazepam following subchronic administration in two patients with renal failure.两名肾衰竭患者亚慢性给药后劳拉西泮清除受损。
Br J Clin Pharmacol. 1981 Nov;12(5):749-51. doi: 10.1111/j.1365-2125.1981.tb01300.x.
7
Pharmacokinetic profile of indoprofen in elderly subjects.吲哚美辛在老年受试者中的药代动力学特征。
Br J Clin Pharmacol. 1986 Dec;22(6):721-4. doi: 10.1111/j.1365-2125.1986.tb02964.x.
8
Biliary excretion of diflunisal conjugates in patients with T-tube drainage.
Eur J Clin Pharmacol. 1988;34(4):423-6. doi: 10.1007/BF00542448.
9
Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.肾衰竭、类风湿关节炎及老年对二氟尼柳药代动力学的影响。
Eur J Clin Pharmacol. 1989;36(2):165-74. doi: 10.1007/BF00609190.
10
Diflunisal and its conjugates in patients with renal failure.双氟尼酸及其结合物在肾衰竭患者中的情况。
Br J Clin Pharmacol. 1991 May;31(5):546-50. doi: 10.1111/j.1365-2125.1991.tb05578.x.
本文引用的文献
1
Restrictions imposed on antibiotic therapy by renal failure.肾衰竭对抗生素治疗的限制。
Arch Intern Med. 1959 Dec;104:1030-50. doi: 10.1001/archinte.1959.00270120186021.
2
Persistence of antibiotics in blood of patients with acute renal failure. III. Penicillin, streptomycin, erythromycin and kanamycin.急性肾衰竭患者血液中抗生素的持续存在情况。III. 青霉素、链霉素、红霉素和卡那霉素。
J Clin Invest. 1959 Sep;38(9):1509-19. doi: 10.1172/JCI103929.
3
Decreased body clearance of diflunisal in renal insufficiency--an alternative explanation.肾功能不全时双氟尼酸的体内清除率降低——另一种解释。
Br J Clin Pharmacol. 1979 Dec;8(6):601. doi: 10.1111/j.1365-2125.1979.tb01055.x.
4
Measurement of clofibric acid (CPIB) metabolites in plasma of patients on clofibrate therapy.氯贝丁酯治疗患者血浆中氯贝酸（CPIB）代谢物的测定。
Clin Exp Pharmacol Physiol. 1979 May-Jun;6(3):267-73. doi: 10.1111/j.1440-1681.1979.tb01248.x.
5
Plasma half-life of clofibric acid in renal failure.氯贝酸在肾衰竭患者中的血浆半衰期。
Br J Clin Pharmacol. 1979 Apr;7(4):407-10. doi: 10.1111/j.1365-2125.1979.tb00956.x.
6
Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency.双氯芬酸在肾功能不全患者体内的生物转化及其葡糖醛酸苷的肾排泄
Br J Clin Pharmacol. 1979 Mar;7(3):273-82. doi: 10.1111/j.1365-2125.1979.tb00932.x.
7
Oxazepam disposition in uremic patients.
Acta Pharmacol Toxicol (Copenh). 1977 Jan;40 Suppl 1(1):52-62.
8
Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate.新型水杨酸盐5-（2'，4'-二氟苯基）水杨酸的生理处置与代谢
Drug Metab Dispos. 1975 Nov-Dec;3(6):453-66.
Zotero 插件